Douglas Adamson

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

John Primrose, Richard Fox, Daniel H. Palmer et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Medicine +10

GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial

Robert Leonard, Douglas Adamson, Gianfilippo Bertelli et al. · Annals of Oncology · 2017 · 149 citations · Full text

Breast Oncology, Early Breast Cancer, Medicine +11

Towards Predicting the Response of a Solid Tumour to Chemotherapy and Radiotherapy Treatments: Clinical Insights from a Computational Model

Gibin Powathil, Douglas Adamson, Mark A. J. Chaplain · PLoS Computational Biology · 2013 · 117 citations · Full text

Engineering, Radiation Effect, Radiation Exposure +24

Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT

Nathan Coombs, Joel M Coombs, Uma J Vaidya et al. · BMJ Open · 2016 · 86 citations · Full text

Diclofenac Antagonizes Peroxisome Proliferator-Activated Receptor-γ Signaling

Douglas Adamson, David Frew, Roger Tatoud et al. · Molecular Pharmacology · 2002 · 84 citations